Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (2011) (ISBN 0309219299) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) (ISBN 030910078X) Committee on Clinical Trial Registries


• Extending Medicare Reimbursement in Clinical Trials (2000) (ISBN 0309068886) Henry J. Aaron and Hellen Gelband, Editors; Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine


• Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary (2010) (ISBN 030911988X) LeighAnne Olsen and J. Michael McGinnis; Roundtable on Value & Science-Driven Health Care; Institute of Medicine


• The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary (2002) (ISBN 0309083494) Sean Tunis, Allan Korn, and Alex Ommaya, Editors, Based on a Workshop of the Clinical Research Roundtable, Board on Health Sciences Policy


• A Report on the Sponsors of Cancer Treatment Clinical Trials and Their Approval and Monitoring Mechanisms (1999) (ISBN NI000611)


• Improving the Quality of Cancer Clinical Trials: Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• Patients Charting the Course: Citizen Engagement in the Learning Health System: Workshop Summary (2011) (ISBN 0309149932) LeighAnne Olsen, Robert S. Saunders, and J. Michael McGinnis, Editors and Rapporteurs; The Learning Health System Series; Institute of Medicine


• Expanding Access to Investigational Therapies for HIV Infection and AIDS (1991) (ISBN 0309044901) Roundtable for the Development of Drugs and Vaccines Against AIDS, Institute of Medicine


• Review of the Fialuridine (FIAU) Clinical Trials (1995) (ISBN 0309052793) Frederick J. Manning and Morton Swartz, Editors; Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine


• Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making: Workshop Report (1999) (ISBN 0309065941) Jonathan R. Davis, Vivian P. Nolan, Janet Woodcock, and Ronald W. Estabrook, Editors; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Institute of Medicine


• Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs (2008) (ISBN 0309111072) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, Nancy E. Adler and Ann E. K. Page, Editors